Modern Pathology

Table 4 Biomarker expression: correlation with clinicopathologic parameters in endometrial carcinoma

From: Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers

	AIB1 (BD^a)				ER				PR (total)				PRB-N				PRB-C
	n	Median	K–W	WRS	n	Median	K–W	WRS	n	Median	K–W	WRS	n	Median	K–W	WRS	n	Median	K–W	WRS
			P	P			P	P			P	P			P	P			P	P
Menopause
Pre	13	80	0.002		14	265	0.84		15	255	0.28		14	105	0.79		14	200	0.42
Peri	10	200			10	210			10	255			10	100			10	170
Post	59	200			60	210			60	202.5			61	120			61	170
Stage
I	54	200		0.09	55	230		0.02	56	240		0.004	56	130		0.31	56	195		0.69
II–IV	18	190			18	160			18	120			18	85			18	160
Grade
I	43	200		0.04	45	250		0.01	46	247.5		0.03	45	120		0.42	45	150		0.05
II/III	38	270			38	200			38	195			39	100			39	200
Histo type
I	67	200		0.07	68	210		0.48	69	210		0.21	69	120		0.09	69	170		0.08
II	14	270			15	270			15	120			15	180			15	200

K–W=Kruskal–Wallis test; WRS=Wilcoxon rank sum test; PRB-N=PR-B isoform nuclear expression; PRB-C=PR-B cytoplasmic expression.
^aBD Bioscience.
Bold values indicate statistically significant P-values.

Back to article page

Search

Advanced search

Quick links